Antioxidant therapy for pain relief in patients with chronic pancreatitis: systematic review and meta-analysis
According to Global Cancer Observatory (GCO), colorectal cancer ranked as the fourth most prevalent malignancy worldwide in 2022, while stomach cancer and oral cancer ranks sixth and 17th respectively
PT-141 has stronger clinical evidence (Phase III, FDA approval)
Rap1-deficient mice did respond to other kinds of anti-diabetic drugs, including insulin and GLP-1 agonists, but the fact that the animals didn't respond to metformin suggests the drug relies on the VMH Rap1 pathway to achieve its effect
Clinical trial data shows diarrhea rates of 19-23% across doses, with nausea remaining the predominant side effect at 24-31%
This approach provides more actionable data for research environments and helps ensure that the results associated with a peptide product are scientifically relevant, transparent, and appropriate for laboratory research use